The regulatory affairs outsourcing market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. Regulatory affairs outsourcing is becoming a common practice in the Pharma and Biotech industry. Outsourcing is also practised in pharmacovigilance as well and most companies are looking for partnerships in order to manage the operational tasks which include report publishing and submission as well. Incidences of rising disease prevalence especially in the regions of Asia Pacific and MEA are driving the growth of the global regulatory affairs outsourcing market in the forecast period. Also, with the advent of new and rare diseases, the number of clinical trials is also increasing, thus leading to an increase in the demand of these services. Furthermore, the growing trend of biosimilars is expected to create a demand for regulatory expertise which will lead to the growth of the regulatory affairs outsourcing market in the forecast period and beyond.
This research study examines the current market trends related to demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the regulatory affairs outsourcing value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and more efficient understanding of the regulatory affairs outsourcing market.
Major industry players profiled as part of the report are Syneos Health, Genpact, CRITERIUM, INC., PRAHEALTHSCIENCES and PMI among others.
The regulatory affairs outsourcing market has been analyzed through following segments:
Cinical Trial Applications
Regulatory Writing and Publishing
Middle East and Africa
Key insights offered
What will be the regulatory affairs outsourcing market size from 2017 to 2023?
How are the major drivers and restraints affecting the regulatory affairs outsourcing market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.
Pharmaceutical Product Development, LLC
PAREXEL International Corporation
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.